![]() G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 1996 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Durham, US HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more |
Employees | Employees 3,9671% decrease | Employees 17015% increase | Employees 75,883 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $7.2m (FY, 2023) | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $75.3m (FY, 2023) | Gross profit $49.8b (FY, 2025) |
Net income | Net income N/A | Net income ($48m) (FY, 2023) | Net income $14b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 289.6m | Total funding raised $ 6.5m |

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View company
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company